Refine
Has Fulltext
- yes (3)
Document Type
- Doctoral Thesis (3)
Is part of the Bibliography
- yes (3)
Keywords
- ATRP (1)
- Bindung (1)
- CBM (1)
- Cellulose-Bindung (1)
- Eisen (1)
- Hepcidin (1)
- Integrin (1)
- Metall (1)
- NMR (1)
- Paxillin (1)
- Peptid (1)
- Protein-Polymer-Konjugat (1)
- RAFT (1)
- Zellmigration (1)
- binding (1)
- biohybrid molecules (1)
- cell migration (1)
- cellulose-binding (1)
- enzymatic conjugation (1)
- focal adhesion (1)
- fokale Adhäsionen (1)
- hepcidin (1)
- iron (1)
- metal (1)
- peptide (1)
- peptide synthesis (1)
- polymerization (1)
- protein polymer conjugate (1)
- sortagging (1)
- sortaseA (1)
Institute
- Institut für Chemie (3)
- Extern (1)
Hepcidin-25 (Hep-25) plays a crucial role in the control of iron homeostasis. Since the dysfunction of the hepcidin pathway leads to multiple diseases as a result of iron imbalance, hepcidin represents a potential target for the diagnosis and treatment of disorders of iron metabolism. Despite intense research in the last decade targeted at developing a selective immunoassay for iron disorder diagnosis and treatment and better understanding the ferroportin-hepcidin interaction, questions remain. The key to resolving these underlying questions is acquiring exact knowledge of the 3D structure of native Hep-25. Since it was determined that the N-terminus, which is responsible for the bioactivity of Hep-25, contains a small Cu(II)-binding site known as the ATCUN motif, it was assumed that the Hep-25-Cu(II) complex is the native, bioactive form of the hepcidin. This structure has thus far not been elucidated in detail. Owing to the lack of structural information on metal-bound Hep-25, little is known about its possible biological role in iron metabolism. Therefore, this work is focused on structurally characterizing the metal-bound Hep-25 by NMR spectroscopy and molecular dynamics simulations. For the present work, a protocol was developed to prepare and purify properly folded Hep-25 in high quantities. In order to overcome the low solubility of Hep-25 at neutral pH, we introduced the C-terminal DEDEDE solubility tag. The metal binding was investigated through a series of NMR spectroscopic experiments to identify the most affected amino acids that mediate metal coordination. Based on the obtained NMR data, a structural calculation was performed in order to generate a model structure of the Hep-25-Ni(II) complex. The DEDEDE tag was excluded from the structural calculation due to a lack of NMR restraints. The dynamic nature and fast exchange of some of the amide protons with solvent reduced the overall number of NMR restraints needed for a high-quality structure. The NMR data revealed that the 20 Cterminal Hep-25 amino acids experienced no significant conformational changes, compared to published results, as a result of a pH change from pH 3 to pH 7 and metal binding. A 3D model of the Hep-25-Ni(II) complex was constructed from NMR data recorded for the hexapeptideNi(II) complex and Hep-25-DEDEDE-Ni(II) complex in combination with the fixed conformation of 19 C-terminal amino acids. The NMR data of the Hep-25-DEDEDE-Ni(II) complex indicates that the ATCUN motif moves independently from the rest of the structure. The 3D model structure of the metal-bound Hep-25 allows for future works to elucidate hepcidin’s interaction with its receptor ferroportin and should serve as a starting point for the development of antibodies with improved selectivity.
Proteine erfüllen bei einer Vielzahl von Prozessen eine essenzielle Rolle. Um diese Funktionsweisen zu verstehen, bedarf es der Aufklärung derer Struktur und deren Bindungsverhaltens mit anderen Molekülen wie Proteinen, Peptiden, Kohlenhydraten oder kleinen Molekülen. Im ersten Teil dieser Arbeit wurden der Wildtyp und die Punktmutante N126W eines Kohlenhydrat-bindenden Proteins aus dem hitzestabilen Bakterium C. thermocellum untersucht, welches Teil eines Komplexes ist, der Kohlenhydrate wie Cellulose erkennen, binden und abbauen kann. Dazu wurde dieses Protein mit E.coli Bakterien hergestellt und durch Metallchelat- und Größenausschlusschromatographie gereinigt. Die Proteine konnten isotopenmarkiert mittels Kernspinresonanz-Spektroskopie (NMR) untersucht werden. H/D-Austauschexperimente zeigten leicht und schwer zugängliche Stellen im Protein für eine mögliche Ligandenwechselwirkung. Anschließend konnte eine Interaktion beider Proteine mit Cellulosefragmenten festgestellt werden. Diese interagieren über zwischenmolekulare Kräfte mit den Seitenketten von aromatischen Aminosäuren und über Wasserstoffbrückenbindungen mit anderen Resten. Weiterhin wurde die Calcium-Bindestelle analysiert und es konnte gezeigt werden, das diese nach der Proteinherstellung mit einem Calcium-Ion besetzt ist und dieses mit dem Komplexbildner EDTA entfernbar ist, jedoch wieder reversibel besetzt werden kann. Zum Schluss wurde mittels zweier Methoden versucht (grafting from und grafting to), das Protein mit einem temperatursensorischen Polymer (Poly-N-Isopropylacrylamid) zu koppeln, um so Eigenschaften wie Löslichkeit oder Stabilität zu beeinflussen. Es zeigte sich, das während die grafting from Methode (Polymer wächst direkt vom Protein) zu einer teilweisen Entfaltung und Destabilisierung des Proteins führte, bei der grafting to Methode (Polymer wird separat hergestellt und dann an das Protein gekoppelt) das Protein seine Stabilität behielt und nur wenige Polymerketten angebaut waren. Der zweite Teil dieser Arbeit beschäftigte sich mit der Interaktion von zwei LIM-Domänen des Proteins Paxillin und der zytoplasmatischen Domäne der Peptide Integrin-β1 und Integrin-β3. Diese spielen eine wichtige Rolle bei der Bewegung von Zellen. Dabei interagieren sie mit einer Vielzahl an anderen Proteinen, um fokale Adhäsionen (Multiproteinkomplexe) zu bilden. Bei der Herstellung des Peptids Integrin-β3 zeigte sich durch Größenausschlusschromatographie und Massenspektrometrie ein Abbau, bei dem verschiedene Aminosäuregruppen abgespalten werden. Dieser konnte durch eine Zugabe des Serinprotease-Inhibitors AEBSF verhindert werden. Anschließend wurde die direkte Interaktion der Proteine untereinander mittels NMR untersucht. Dabei zeigte sich, das Integrin-β1 und Integrin-β3 an die gleiche Position binden, nämlich an den flexiblen Loop der LIM3-Domäne von Paxillin. Die Dissoziationskonstanten zeigten, dass Integrin-β1 mit einer zirka zehnfach höheren Affinität im Vergleich zu Integrin-β3 an Paxillin bindet. Während Paxillins Bindestelle an Integrin-β1 in der Mitte des Peptids liegt, ist bei Integrin-β3 der C-Terminus essenziell. Daher wurden die drei C-terminalen Aminosäuren entfernt und erneut Bindungsstudien durchgeführt, welche gezeigt haben, das die Affinität dadurch fast vollständig unterbunden wurde. Final wurde der flexible Loop der LIM3-Domäne in zwei andere Aminosäuresequenzen mutiert, um die Bindung auf der Paxillin-Seite auszulöschen. Jedoch zeigten sowohl Zirkulardichroismus-Spektroskopie als auch NMR-Spektroskopie, dass die Mutationen zu einer teilweisen Entfaltung der Domäne geführt haben und somit nicht als geeignete Kandidaten für diese Studien identifiziert werden konnten.
During the last decades, therapeutical proteins have risen to great significance in the pharmaceutical industry. As non-human proteins that are introduced into the human body cause a distinct immune system reaction that triggers their rapid clearance, most newly approved protein pharmaceuticals are shielded by modification with synthetic polymers to significantly improve their blood circulation time. All such clinically approved protein-polymer conjugates contain polyethylene glycol (PEG) and its conjugation is denoted as PEGylation. However, many patients develop anti-PEG antibodies which cause a rapid clearance of PEGylated molecules upon repeated administration. Therefore, the search for alternative polymers that can replace PEG in therapeutic applications has become important. In addition, although the blood circulation time is significantly prolonged, the therapeutic activity of some conjugates is decreased compared to the unmodified protein. The reason is that these conjugates are formed by the traditional conjugation method that addresses the protein's lysine side chains. As proteins have many solvent exposed lysines, this results in a somewhat uncontrolled attachment of polymer chains, leading to a mixture of regioisomers, with some of them eventually affecting the therapeutic performance.
This thesis investigates a novel method for ligating macromolecules in a site-specific manner, using enzymatic catalysis. Sortase A is used as the enzyme: It is a well-studied transpeptidase which is able to catalyze the intermolecular ligation of two peptides. This process is commonly referred to as sortase-mediated ligation (SML). SML constitutes an equilibrium reaction, which limits product yield. Two previously reported methods to overcome this major limitation were tested with polymers without using an excessive amount of one reactant.
Specific C- or N-terminal peptide sequences (recognition sequence and nucleophile) as part of the protein are required for SML. The complementary peptide was located at the polymer chain end. Grafting-to was used to avoid damaging the protein during polymerization. To be able to investigate all possible combinations (protein-recognition sequence and nucleophile-protein as well as polymer-recognition sequence and nucleophile-polymer) all necessary building blocks were synthesized. Polymerization via reversible deactivation radical polymerization (RDRP) was used to achieve a narrow molecular weight distribution of the polymers, which is required for therapeutic use.
The synthesis of the polymeric building blocks was started by synthesizing the peptide via automated solid-phase peptide synthesis (SPPS) to avoid post-polymerization attachment and to enable easy adaptation of changes in the peptide sequence. To account for the different functionalities (free N- or C-terminus) required for SML, different linker molecules between resin and peptide were used.
To facilitate purification, the chain transfer agent (CTA) for reversible addition-fragmentation chain-transfer (RAFT) polymerization was coupled to the resin-immobilized recognition sequence peptide. The acrylamide and acrylate-based monomers used in this thesis were chosen for their potential to replace PEG.
Following that, surface-initiated (SI) ATRP and RAFT polymerization were attempted, but failed. As a result, the newly developed method of xanthate-supported photo-iniferter (XPI) RAFT polymerization in solution was used successfully to obtain a library of various peptide-polymer conjugates with different chain lengths and narrow molar mass distributions.
After peptide side chain deprotection, these constructs were used first to ligate two polymers via SML, which was successful but revealed a limit in polymer chain length (max. 100 repeat units). When utilizing equimolar amounts of reactants, the use of Ni2+ ions in combination with a histidine after the recognition sequence to remove the cleaved peptide from the equilibrium maximized product formation with conversions of up to 70 %.
Finally, a model protein and a nanobody with promising properties for therapeutical use were biotechnologically modified to contain the peptide sequences required for SML. Using the model protein for C- or N-terminal SML with various polymers did not result in protein-polymer conjugates. The reason is most likely the lack of accessibility of the protein termini to the enzyme. Using the nanobody for C-terminal SML, on the other hand, was successful. However, a similar polymer chain length limit was observed as in polymer-polymer SML. Furthermore, in case of the synthesis of protein-polymer conjugates, it was more effective to shift the SML equilibrium by using an excess of polymer than by employing the Ni2+ ion strategy.
Overall, the experimental data from this work provides a good foundation for future research in this promising field; however, more research is required to fully understand the potential and limitations of using SML for protein-polymer synthesis. In future, the method explored in this dissertation could prove to be a very versatile pathway to obtain therapeutic protein-polymer conjugates that exhibit high activities and long blood circulation times.